2 resultados para dividing lines

em Universidad del Rosario, Colombia


Relevância:

60.00% 60.00%

Publicador:

Resumo:

Desde la disolución de la Unión Soviética, los países de Europa Oriental, en particular Ucrania y Bielorrusia, son partícipes de una disputa por el liderazgo de la región entre la OTAN y Rusia. Esta disputa presenta una paradoja para los países en cuestión, ya que mientras se ven imposibilitados para cambiar el estado de estas relaciones, éstas afectan directamente la seguridad nacional de los mismos. La lucha por el poder y la búsqueda de los intereses particulares han generado que esta zona se convierta en un espacio altamente influenciado tanto por la OTAN como por Rusia, lo cual ha hecho que la suerte de esta región dependa de terceros y no de sus propios gobiernos.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

This study covers an area of great importance in the research of breast cancer, related to the study of the effects of both estrogens (E2) and anti-estrogens (Tamoxifen) on chromosomes and of modulation of gene expression. Considering that breast cancer is a very heterogeneous disease and that patients respond differently to treatment, the identification of chromosomal abnormalities as well as genes responsive to 17β-estradiol (E2) and Tamoxifen (TAM) could provide the necessary framework to understand the complex effects of this hormone in target cells and could explain, at least in part, the development of cellular resistance to TAM treatment and the subsequent best therapeutic option. In this order of ideas, we determined the effects of E2 and TAM on the chromosomes and on the modulation of gene expression in four breast cancer cell lines, which represent three of the five subtypes of breast cancer known at present. The results are presented in six chapters - each one has a group of the results achieved around the cytogenetic characteristics and gene expression profiles of four cell lines and the effects of E2 and TAM incubation on those. The first chapter describes the main features of breast cancer, furthering the use and effects of E2 and TAM treatment.